Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MAP4K4 | O95819 | 6/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.41 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.41 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17066358 | 0.83 | CYP2A6 (0.52) | CYP2A6NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL313209 | 0.81 | MAP4K4 (0.58) | CYP1A2CYP3A4CYP2C19MAP4K4KCNH2 | |
| SCHEMBL23319645 | 0.79 | ESR2 (0.54) | CYP2A6NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL18136475 | 0.79 | PSMB5 (0.53) | CYP2A6NPC1RAB9ASMN1; SMN2MAPT | |
| Hydrochloric Acid SCHEMBL7157212 | 0.78 | CYP2A6 (0.50) | CYP3A4CYP2A6NPC1RAB9AMAPT | |
| SCHEMBL11072484 | 0.77 | ALDH1A1 (0.56) | CYP1A2CYP3A4CYP2C19NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL11064856 | 0.75 | CHRNA7 (0.45) | CYP1A2CYP3A4CYP2C19NPC1RAB9A | |
| SCHEMBL11064733 | 0.75 | MAP4K4 (0.50) | NPC1RAB9ASMN1; SMN2MAP4K4HTT | |
| SCHEMBL14478722 | 0.74 | MAP4K4 (0.50) | CYP2A6NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL2757262 | 0.74 | NPSR1 (0.55) | CYP1A2CYP3A4CYP2C19NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9556172-B2 | Processes for the manufacture of propane-1-sulfonic acid (3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl)-amide | HOFFMAN LA-ROCHE INC. (US) | 2017-01-31 | — | — | US | disclosed |
| US-20160083378-A1 | NOVEL PROCESSES FOR THE MANUFACTURE OF PROPANE-1-SULFONIC ACID (3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-b]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL)-AMIDE | HOFFMANN LA ROCHE (US) | 2016-03-24 | — | — | US | disclosed |
| US-9150594-B2 | Processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide | HOFFMANN-LA ROCHE INC. (US) | 2015-10-06 | — | — | US | disclosed |
| US-20140288308-A1 | NOVEL PROCESSES FOR THE MANUFACTURE OF PROPANE-1-SULFONIC ACID -AMIDE | HOFFMANN LA ROCHE (US) | 2014-09-25 | — | — | US | disclosed |
| US-8779150-B2 | Processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1 H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide | HOFFMANN-LA ROCHE INC. (US) | 2014-07-15 | — | — | US | disclosed |
| US-20120022258-A1 | Novel Processes for the manufacture of Propane-1-sulfonic acid -amide | F. HOFFMANN-LA ROCHE AG (CH) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288308-A1 | NOVEL PROCESSES FOR THE MANUFACTURE OF PROPANE-1-SULFONIC ACID -AMIDE | SULT1A1, FASN, COASY | CYP1A2 55/4885CYP3A4 91/4885CYP2C19 276/4885 |
| US-20160083378-A1 | NOVEL PROCESSES FOR THE MANUFACTURE OF PROPANE-1-SULFONIC ACID (3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-b]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL)-AMIDE | ALDH18A1, PFAS, PCCA | CYP1A2 47/4885CYP3A4 59/4885CYP2C19 204/4885 |
| US-20120022258-A1 | Novel Processes for the manufacture of Propane-1-sulfonic acid -amide | SULT1A1, FASN, COASY | CYP1A2 55/4885CYP3A4 91/4885CYP2C19 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.